BioSpace News Archive

Policy

Statement from the Chief Public Health Officer of Canada on July 19, 2020

In lieu of an in-person update to the media, Dr. Howard Njoo, Canada’s Deputy Chief Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada’s Chief Public Health Officer.

July 19, 2020
·
1 min read
Policy

Bridging Study in China Completed for NASH Drug Candidate ASC40

Ascletis Pharma Inc. announces that a single-dose, pharmacokinetic bridging study of non-alcoholic steatohepatitis drug candidate ASC40 in 34 Chinese subjects has been completed and data indicates that key pharmacokinetic parameters are consistent between subjects in China and in the United States.

July 19, 2020
·
2 min read
Deals

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, announced that it has successfully closed US$97 million in Series C financing.

July 19, 2020
·
8 min read